Product custom-nanocomposites-lipid-nanoparticle-composite-materials

Home > products > custom-nanocomposites> lipid-nanoparticle-composite-materials

Catalog	name	Description	price
R-Mcs-499	Liposomes simultaneously loaded with siRNA+methylprednisolone,±100nm	Liposomes loaded with siRNA and methylprednisolone (~100 nm) is a dual functional nano delivery system that can synergistically encapsulate small interfering RNA (siRNA) and methylprednisolone (MP), with a particle size controlled at approximately 100 nm. It has high cellular uptake ability and potential for inflammation/tumor targeting, making it suitable for gene drug co delivery therapy strategies.	price>
R-Mcs-501	LipoCP loaded curcumin and PDA,100nm-200nm	LipoCP loaded curcumin and PDA(Curcumin content 21mg, PDA content 21mg),100nm-200nm is a multifunctional liposome nanocarrier with a particle size controlled within the range of 100-200 nm. It can co load curcumin and polydopamine (PDA), and has the potential for antioxidant, anti-inflammatory, photothermal conversion, and tumor targeting. It is suitable for synergistic therapy and integrated diagnosis and treatment research of cancer.	price>
R-Mcs-502	LipoC loaded curcumin,100nm-200nm	LipoC loaded curcumin (100-200 nm) is a curcumin liposome nano delivery system with particle size controlled within the range of 100-200 nm. It is designed to enhance the stability, bioavailability, and targeting of curcumin, and is suitable for research in tumor therapy, anti-inflammatory intervention, and oxidative stress-related diseases.	price>
R-Mcs-503	LiPOP loaded PDA(polydopamine)	LipoCP loaded PDA (polydopamine) is a type of polydopamine (PDA) loaded liposome nanocarrier designed specifically for the integration of photothermal therapy, drug delivery, and diagnosis and treatment research. It has excellent biocompatibility, photothermal conversion ability, and potential for passive tumor targeting.	price>
R-Mcs-504	Na2CO3 modified hollow MnO2,100-150nm	Hollow MnO2 nanoparticles (100-150nm) modified with Na2CO3/Na2CO3 modified hollow MnO2 are inorganic nanomaterials with alkaline surface functionalization and special hollow mesoporous structure, exhibiting excellent performance in catalysis, adsorption, energy storage, and biomedical fields. Its particle size range is 100-150nm, and combined with the surface charge regulation and introduction of alkaline active sites brought by sodium carbonate (Na ₂ CO3) treatment, it significantly enhances the dispersibility, reactivity, and loading capacity of the material.	price>
R-Mcs-505	PEG modification(hollow MnO2 modified with Na2CO3),100-150nm	PEG modification(hollow MnO2 modified with Na2CO3),100-150nm are a multifunctional inorganic organic hybrid nanoplatform that exhibits synergistic performance in biomedical, catalytic, and environmental remediation fields. This material is centered around hollow MnO ₂ particles with a diameter of 100-150nm. After surface treatment with Na ₂ CO ₂, a PEG polymer layer is further introduced, significantly improving its water dispersibility, biocompatibility, and cycling stability. It is particularly suitable for in vivo drug delivery and tumor microenvironment response therapy.	price>
R-Mcs-506	PEG-(hollow MnO2 modified with Na2CO3)@lactate oxidase	PEG-(hollow MnO2 modified with Na2CO3)@lactate oxidase/PEG modification(hollow MnO2 modified with Na2CO3)Encapsulated lactate oxidase/PEG modification(hollow manganese dioxide modified with sodium carbonate)Encapsulated lactate oxidase are an intelligent biological nanoplatform that integrates nanocarriers, enzyme catalysis, and microenvironment regulation. It is designed specifically for tumor metabolism intervention, hypoxia relief, and immune microenvironment remodeling. The system is based on hollow MnO ₂ with a particle size of 100-150nm. After alkaline modification on the surface of Na ₂ CO3, a polyethylene glycol (PEG) layer is introduced, and lactate oxidase (LOx) is covalently or physically coupled to achieve targeted clearance of high concentrations of lactate and in-situ generation of reactive oxygen species (ROS) in the tumor microenvironment.	price>
R-Mcs-507	PEG-(hollow MnO2 modified with Na2CO3)@lactate oxidase +Digoxin	PEG-(hollow MnO2 modified with Na2CO3)@lactate oxidase +Digoxin/PEG modification(hollow MnO2 modified with Na2CO3)Encapsulated lactate oxidase+Digoxin/PEG modification(hollow manganese dioxide modified with sodium carbonate)Encapsulated lactate oxidase +Digoxin are a multifunctional nanocomposite system that integrates nanocarriers, enzyme catalysis, and cardiac glycoside drugs. It has the potential to be applied in tumor microenvironment regulation and cardiovascular drug synergistic intervention. The system is based on a hollow MnO ₂ substrate with a wavelength of 100-150nm. After alkaline modification of the Na ₂ CO3 surface, a PEG layer is introduced to further couple lactate oxidase (LOx), which can be used in combination with digoxin to achieve a synergistic effect of metabolic intervention and drug therapy.	price>
R-Mcs-508	SiP4HA2-Daunorubicin-liposome(<160nm)	SiP4HA2-Daunorubicin-liposome(<160nm) is a multifunctional anti-tumor system based on small interfering RNA (siRNA) targeted regulation, doxorubicin drug loading, and liposome nanocarrier binding, aiming to achieve gene drug synergistic therapy for malignant tumors such as liver cancer.	price>
R-Mcs-509	SiP4HA2-Doxorubicin-CXCR4-Liposomes(FAM labeled)	SiP4HA2-Doxorubicin-CXCR4-Liposomes(FAM labeled,particle size<160nm) is a multifunctional nanoliposome system that integrates gene interference, chemotherapy drug delivery, active targeting, and fluorescence tracing. It is designed to enhance tumor targeting and synergistic therapeutic effects, and is particularly suitable for malignant tumors with high expression of CXCR4 receptors such as liver cancer and lung cancer.	price>

...